These outcomes, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the concept of targeting ACKR3 as a unique technique to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant Issues. Take note: Effects might differ about https://samuelr470yvr1.wikijournalist.com/user